Pharmaceutical companies proposed to abolish the principle of “the third wheel”

International pharmaceutical companies called for the abolition of the principle of “third wheel” in public procurement of medicines for treatment of socially significant diseases, writes “Kommersant”. Earlier, the government proposed to abolish this approach when gostorg for a list of drugs bought under trade names, but according to the companies, this is a formal solution of the problem.

The principle of “three’s a crowd” applies to the procurement of medicines and medical products. If the gostorg out two or more Russian manufacturer of purchased goods, foreign companies can not participate in this auction. This practice has repeatedly caused criticism, as stimulated purchases of the cheaper pharmaceuticals, which could be side effects.

In February, the government gave the Ministry of health instructions so as to facilitate the procurement practices of a particular treatment— in particular, it was proposed to use so-called list of drugs that can be purchased under trade names. The Agency, in turn, offered not to distribute it on the principle of “odd”. But, according to the letter of the Association “Infarma”, this approach is unlikely to help patients to access necessary drugs. The list of drugs procured in accordance with their trade names, 2013 has not been formed and approved, and the draft decree proposed by the Ministry of health proposes changes to the idle machinery.

It would be more efficient to replace a non-existent list of drugs on the list of socially significant diseases and bring it out of the principle of “three’s company” follows from the letter of the Association.

In this list — a number of cardiovascular diseases, cancer, diabetes, HIV, tuberculosis and hepatitis, venereal diseases and mental disorders. As a result of the actions of “Ted” will withdraw all drugs from the essential drugs list (mostly public procurement). “Health workers should be guided by quality, effectiveness and safety of the drug, not the country in which the drug is produced. Unfortunately, we have to state that the Ministry of health approach is not conducive to solving the problem of selection of effective therapy and individual therapy for patients, including minors,”— said the head of the Association Vadim Kukava.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]